Pages without language links
Jump to navigation
Jump to search
The following pages do not link to other language versions.
Showing below up to 50 results in range #109,751 to #109,800.
- The Forsyth Institute
- The Frankenfood Myth
- The Fred Hollows Foundation
- The GENESIS Trial Demonstrates Disappointing Results With Pimecrolimus Eluting Stents
- The GISSI-HF trial suggests long-term treatment with n-3 PUFAs provides moderate clinical benefits for chronic heart failure patients
- The GRACE risk score
- The George Foundation
- The George Institute for International Health
- The Global Fund to Fight AIDS, Tuberculosis and Malaria
- The Golden Book of Chemistry Experiments
- The Gothenburg Study of Children with DAMP
- The Grit
- The Group Selection Squad
- The Hacker's Diet
- The Heart in Insulin Dependent Diabetes Mellitus
- The Heart in Köhlmeier-Degos Disease
- The Heuga Center for Multiple Sclerosis
- The Homelessness Project
- The Hormone Foundation
- The Inner Life of the Cell
- The Instance of the Letter in the Unconscious, or Reason Since Freud
- The Institute for Genomic Research
- The Institute of Living
- The International Journal of Psychiatry
- The International Paleopsychology Project
- The International Society of Pharmacovigilance
- The Israel Journal of Psychiatry and Related Sciences
- The JUPITER Trial
- The Jimmy Fund
- The Journal of Medical Practice Management
- The Kurtzke Expanded Disability Status Scale (EDSS)
- The Lancet
- The Leaf (AI) Project
- The Learning Center for Deaf Children
- The Living Guidelines:UA/NSTEMI Antiplatelet Therapy
- The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI Polling Results for CLASS III Guidelines
- The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI Polling Results for CLASS I Guidelines
- The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI Suggest Revisions to the CLASS III Guidelines
- The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI View the Current CLASS III Guidelines
- The Living Guidelines: Ancillary Therapy for Patients Undergoing PCI for STEMI View the Current CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin Polling Results for CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin Suggest Revisions to the CLASS IIa Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin Suggest Revisions to the CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin View the Current CLASS IIa Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Aspirin View the Current CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel Polling Results for CLASS IIa Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel Polling Results for CLASS I Guidelines
- The Living Guidelines: Antiplatelet Agents/Anticoagulants: Clopidogrel Suggest Revisions to the CLASS IIa Guidelines